February 2022 - Page 2 of 26

MondayFeb 28, 2022 10:09 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Impressive Testing Results for Next-Gen Battery Technology

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, provided an update on its next-generation solid-state polymer battery technology, which is a significant advancement over today’s current lithium-ion batteries. According to the update, Mullen’s testing of solid-state polymer cells reveals the potential for a 150-kilowatt-hour battery pack that delivers over 600-plus miles of range and highlights an 18-minute DC fast charge, which can yield over 300 miles of range. The company is working towards utilizing solid-state polymer battery packs in its second generation Mullen FIVE EV Crossovers, with in-vehicle prototype testing set for 2025. “We’ve conducted successful testing and…

MondayFeb 28, 2022 9:45 am

American Cannabis Partners M&A Strategy Key Component of Growth Plan

Report notes that global mergers and acquisition will continue into new year ACP performs months of due diligence before acquiring any properties Company exploring land acquisition, project development strategies for expanding operations to two more states this year Mergers and acquisitions (M&A) appear to be a key component for companies looking to grow, with a recent 2022 Global M&A Trends Report indicating that M&A will continue in the new year (https://ibn.fm/BWtXR). Contending for first place in the U.S. cannabis industry, American Cannabis Partners (“ACP”) relies on proven strategies such as mergers and acquisitions to strengthen its position in a competitive…

MondayFeb 28, 2022 9:45 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Tackles Pandemic-era Mental Health Crises with Product R&D and Educational Efforts for the Application of Psychedelics Technology

Delic Holdings Corp is a leader in new medicines and treatments for a modern world with a focus on improving access to health benefits across the country through an integrated, scalable approach to meeting patients’ mental wellness needs Delic has built a three-pronged ecosystem that includes Ketamine Wellness Centers (“KWC”), the largest chain of wellness clinics providing ketamine treatments in the U.S.; Reality Sandwich and Meet Delic, media properties providing education on psychedelics; and DELIC Labs, a federally-authorized research facility The company’s CSO has spoken at a number of conferences on the importance of controlling the extraction production processes for…

MondayFeb 28, 2022 9:30 am

GreenBox POS (NASDAQ: GBOX) and Cross River Join Forces to Create First Banking-as-a-Service Initiative

GreenBox will build the first banking-as-a-service initiative, catapulting the company into the same playing field as other major FinTech-driven brands CEO Fredi Nisan said the initiative will be a game changer for the company, expanding its capabilities and potential customer base, while also serving as a significant driver of revenue growth The partnership will provide additional services to existing clients on a single, seamless platform with a full suite of services that position the two companies to be a vertically-integrated full solution service GreenBox POS (NASDAQ: GBOX), an emerging financial technology (FinTech) company that leverages proprietary security and token technology to…

MondayFeb 28, 2022 9:30 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Agreement Injects Capital, Expands International Distribution Opportunities

The company recently announced a strategic private placement executed with agribusiness Nurture Healthy Foods to bring in just over $5 million in capital at $0.75 for M&A and general operations Plant-based consumer products brand builder Eat Well Investment Group Inc. is a growing investment company operating in North American markets Eat Well’s agreement with Nurture Healthy Foods includes an economic interest in Eat Well’s majority ownership of Amara Organic Foods, a growing manufacturer of plant-based baby foods The company’s products are also gaining increased distribution through companies such as Walmart, Whole Foods, Sprouts Farmer’s Market, Loblaws and HEB Grocery Company…

MondayFeb 28, 2022 9:15 am

As It Targets Multiple Large Market Opportunities, Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Leveraging Elaborate Studies to Progressively Remove Risks Associated with Commercialization, Regulation

Leveraging the versatility and benefits of its DehydraTECH(TM) technology, Lexaria is targeting multiple large market opportunities as it attempts to ensure it has multiple paths to success The technology aims to help companies offering oral drugs, supplements, and nicotine formulations to improve the effectiveness of their existing or planned products Lexaria has undertaken various studies whose findings show the benefits of DehydraTECH-processed products relative to controls The company intends to use the positive results from its studies to incrementally remove risks associated with commercialization and regulation Lexaria Bioscience (NASDAQ: LEXX), a global drug delivery technology company transforming existing consumer products…

MondayFeb 28, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005

Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds Mydecine’s patent-pending dermal route to administration also offers more control over the drug while possibly eliminating undesirable properties such as nausea The company is excited about this finding, terming it one of the many exciting drug discoveries it looks to share in the near term Microdosing, the act of consuming a minimal dose of a psychedelic to benefit from what it offers without going through a…

MondayFeb 28, 2022 9:00 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Banking on an Education-Oriented Approach to Grow its Customer Base and Increase Revenue

PlantX recently added a new YouTube educational series to its channel- “Medically Speaking” This new series will complement the company’s growing body of resources, including podcasts, blogs, and articles posted on its website Mr. Sean Dollinger, the Founder of PlantX, recognizes that there is a growing need and demand for engaging plant-based educational opportunities The company seeks to capitalize on this education-oriented approach to empower its audience and help them overcome barriers to change in their journey towards adopting a plant-based lifestyle It is estimated that around 2 billion people globally live on a largely meat-based diet, while 4 billion…

MondayFeb 28, 2022 9:00 am

Friendable Inc. (FDBL) Providing Alternative in the Wake of Spotify Controversy

Friendable’s offering of the Fan Pass Live artist platform and acquisition of Artist Republik provide musical artists with an “anti-label” set of tools to produce, perform, and distribute music Pulling music from Spotify is not always the best option, especially when artists need that revenue Fan Pass Live offers artists an alternative to lower-paying platforms, allowing artists to keep 100% of ticket sales and tips while receiving revenue from other sources on the platform Friendable posts additional contests on Instagram for artists on the platform to participate in to win monetary and physical prizes The controversy surrounding the recent string…

FridayFeb 25, 2022 1:32 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Optimistic of Positive Study Results, Eyes ‘Most Exciting Year Ever’

Lexaria Bioscience Corp. (NASDAQ: LEXX) achieved myriad milestones in 2021, with CEO Chris Bunka noting in an annual letter to shareholders that January 2021 marked the birth of a modern version of the company. A recent article contains excerpts from the letter, in which Bunka writes, “During 2021, we completed research & development (‘R&D’) and validating work equal to or greater than all the combined amount previously completed since 2018! We have conducted studies across broad areas of interest but also concentrated in specific areas where we have supportive data,” In 2021, Lexaria’s most significant area of investigation was DehydraTECH(TM)-processed…

Site Search

Company Search

Month: February 2022